Vijaya Diagnostic Centre Share Price Targets
Vijaya Diagnostic Centre Limited | |||
 | Price: ₹1,028.15 (-1.71%) | ||
| 52 Week Low: ₹740.00 52 Week High: ₹1,275.00 | |||
| Market Capital: 7,950.62 Crore (Midcap) | |||
| Healthcare -> Diagnostics & Research | |||
Vijaya Diagnostic Centre Stock Comparison: Vijaya Diagnostic Centre vs Metropolis Healthcare | Vijaya Diagnostic Centre vs Thyrocare Technologies | Vijaya Diagnostic Centre vs Krsnaa Diagnostics | Vijaya Diagnostic Centre vs Procter & Gamble Health | Vijaya Diagnostic Centre vs Strides Pharma Science | Vijaya Diagnostic Centre vs FDC | |||
Show Table of Contents
Table of Contents
Vijaya Diagnostic Centre Recent Performance
Over the past 418 trading days, the value of Vijaya Diagnostic Centre's stock has gained ₹458.20 (+80.68%). On 07 Nov 2023, one share was worth ₹567.90 and by 18 Jul 2025, the value jumped to ₹1026.10. During this period it created a highest high of ₹1275.00 and lowest low of ₹563.05.
Vijaya Diagnostic Centre Share Price Target - Tomorrow
| Level | Value | Analysis |
|---|---|---|
| Tomorrow Target 3 | 1130 (+9.9%) | Price Action: 20 Mar 2025 High |
| Tomorrow Target 2 | 1107.65 (+7.73%) | Price Action: Oct 2024 High |
| Tomorrow Target 1 | 1095.1 (+6.51%) | Price Action: 22 Apr 2025 Low |
| Current Price | 1028.15 | Vijaya Diagnostic Centre's share price as of 18 Jul 2025 |
| Stop Loss 1 | 965.65 (-6.08%) | Price Action: 02 Jun 2025 High |
| Stop Loss 2 | 955.65 (-7.06%) | Price Action: 19 Jun 2025 High |
| Stop Loss 3 | 946 (-8%) | Price Action: 20 Jun 2025 High |
Summary
18 Jul 2025: Vijaya Diagnostic Centre finished the day at ₹1028.15, losing ₹-19.90 (-1.90%) in 1 day.
Our analysis for tomorrow predicts a potential movement of -7.99% to 9.91% with:
- Target prices: ₹1095.1 to ₹1130
- Support levels: ₹965.65 to ₹946
- Recent high: ₹1055.90
- Recent low: ₹1025.60
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Vijaya Diagnostic Centre Share Price Target - Next Week
| Level | Value | Analysis |
|---|---|---|
| Next Week Target 3 | 1072 (+4.26%) | Price Action: 04 Mar 2025 High |
| Next Week Target 2 | 1054.6 (+2.57%) | Price Action: May 2025 High |
| Next Week Target 1 | 1043.75 (+1.51%) | Price Action: 20 Mar 2025 Low |
| Current Price | 1028.15 | Vijaya Diagnostic Centre's share price as of 18 Jul 2025 |
| Stop Loss 1 | 1022 (-0.6%) | Price Action: 25 Apr 2025 Low |
| Stop Loss 2 | 999 (-2.84%) | Price Action: 25 Mar 2025 Low |
| Stop Loss 3 | 989 (-3.81%) | Price Action: 01 Jul 2025 High |
Weekly Target Summary
For next week, our analysis suggests a potential movement range of -3.81% to 4.26% with:
- Upper targets: ₹1043.75 to ₹1072
- Support levels: ₹1022 to ₹989
Vijaya Diagnostic Centre Share Price Target - Next Month
| Level | Value | Analysis |
|---|---|---|
| Next Month Target 3 | 1159.4 (+12.76%) | Price Action: Mar 2025 High |
| Next Month Target 2 | 1130 (+9.9%) | Price Action: 20 Mar 2025 High |
| Next Month Target 1 | 1112 (+8.15%) | Price Action: 21 Apr 2025 High |
| Current Price | 1028.15 | Vijaya Diagnostic Centre's share price as of 18 Jul 2025 |
| Stop Loss 1 | 999 (-2.84%) | Price Action: 25 Mar 2025 Low |
| Stop Loss 2 | 989 (-3.81%) | Price Action: 01 Jul 2025 High |
| Stop Loss 3 | 979.05 (-4.78%) | Price Action: 28 Feb 2025 High |
Monthly Target Summary
Looking ahead to next month, technical analysis indicates:
- Potential price movement: -4.78% to 12.77% with:
- Target range: ₹1112 to ₹1159.4
- Support levels: ₹999 to ₹979.05
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
